sing virtual reality at home to treat chronic temporomandibular joint disorders

Not Applicable

Completed

• Conditions: Treatment of chronic pain in patients with temporomandibular joint disorders; Musculoskeletal Diseases

• Registration Number: ISRCTN12473220
• Lead Sponsor: niversity of Maryland, Baltimore

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-05-11
• Study Start: 2023-07-18
• Last Update Posted: 2 August 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

1. Age (18-75 years old)
2. English speaker (written and spoken)
3. Temporal Mandibular Disorder (TMD) for at least 3 months
4. TMD Grade Chronic Pain Scale (GCPS) =1
5. TMD Screening from HP-00068315 2016 and after

Exclusion Criteria

1. Present or past degenerative neuromuscular disease
2. Cardiovascular, neurological diseases, pulmonary abnormalities, kidney disease, liver disease, history of cancer within past 3 years
3. Any personal (or family first degree) history of mania, schizophrenia, or other psychoses
4. Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, autism) leading to hospitalization within the last 3 years.
5. Lifetime alcohol/drug dependence or alcohol/drug abuse in past 3 months
6. Pregnancy or breast feeding
7. Color-blindness
8. Impaired or uncorrected hearing
9. Any facial trauma that has occurred in the last 6 weeks
10. History of a severe facial trauma in the last 2-3 months
11. Conditions that would interfere with the VR mask placement (e.g. trauma, burn, infection)
12. Known history of severe motion sickness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Daily pain intensity levels will be measured using visual analogue scale (VAS) from 0=no pain at all to 100=maximum tolerable pain.

Secondary Outcome Measures

Name	Time	Method
<br> 1. Daily pain unpleasantness, anxiety, mood will be measured using VAS from 0=no pain unpleasantness/no anxiety at all/extremely bad to 100=maximum pain unpleasantness/maximum tolerable anxiety/extremely good.<br> 2. Weekly pain behavior, pain interference, anxiety, and sleep disturbances will be measured using Patient Reported Outcome Measurement Information Systems (PROMIS) tools.<br>